213 related articles for article (PubMed ID: 19139131)
1. Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation.
Coleman DT; Bigelow R; Cardelli JA
Mol Cancer Ther; 2009 Jan; 8(1):214-24. PubMed ID: 19139131
[TBL] [Abstract][Full Text] [Related]
2. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
[TBL] [Abstract][Full Text] [Related]
3. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
Lupu R; Menendez JA
Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
[TBL] [Abstract][Full Text] [Related]
6. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
7. Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing.
Kakazu A; Sharma G; Bazan HE
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2927-35. PubMed ID: 18579758
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma.
Uddin S; Hussain AR; Ahmed M; Bu R; Ahmed SO; Ajarim D; Al-Dayel F; Bavi P; Al-Kuraya KS
Mol Cancer Ther; 2010 May; 9(5):1244-55. PubMed ID: 20423996
[TBL] [Abstract][Full Text] [Related]
9. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells.
Duhon D; Bigelow RL; Coleman DT; Steffan JJ; Yu C; Langston W; Kevil CG; Cardelli JA
Mol Carcinog; 2010 Aug; 49(8):739-49. PubMed ID: 20623641
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway.
Lim CS; Walikonis RS
Cell Signal; 2008 May; 20(5):825-35. PubMed ID: 18262389
[TBL] [Abstract][Full Text] [Related]
11. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.
Dai Y; Siemann DW
Mol Cancer Ther; 2010 Jun; 9(6):1554-61. PubMed ID: 20515943
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
[TBL] [Abstract][Full Text] [Related]
13. Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
Relat J; Blancafort A; Oliveras G; CufĂ S; Haro D; Marrero PF; Puig T
BMC Cancer; 2012 Jul; 12():280. PubMed ID: 22769244
[TBL] [Abstract][Full Text] [Related]
14. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of FASN inhibition in preclinical models of HCC.
Wang H; Zhou Y; Xu H; Wang X; Zhang Y; Shang R; O'Farrell M; Roessler S; Sticht C; Stahl A; Evert M; Calvisi DF; Zeng Y; Chen X
Hepatology; 2022 Oct; 76(4):951-966. PubMed ID: 35076948
[TBL] [Abstract][Full Text] [Related]
16. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
17. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.
Brusselmans K; Vrolix R; Verhoeven G; Swinnen JV
J Biol Chem; 2005 Feb; 280(7):5636-45. PubMed ID: 15533929
[TBL] [Abstract][Full Text] [Related]
18. Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway.
Takeuchi K; Ito F
J Biol Chem; 2004 Jan; 279(2):892-900. PubMed ID: 14570904
[TBL] [Abstract][Full Text] [Related]
19. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.
Leelawat K; Leelawat S; Tepaksorn P; Rattanasinganchan P; Leungchaweng A; Tohtong R; Sobhon P
J Surg Res; 2006 Nov; 136(1):78-84. PubMed ID: 16950403
[TBL] [Abstract][Full Text] [Related]
20. Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells.
Hwang ST; Um JY; Chinnathambi A; Alharbi SA; Narula AS; Namjoshi OA; Blough BE; Ahn KS
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]